Improving type 1 diabetes care

(From left) Roche Diagnostics Malaysia general manager Heng Chai Yin, Koh, MEMS vice-president Prof Dr Muhammad Yazid Jalaludin, Dr Mohd Azman, Dr Nurain, Anand and Novo Nordisk Malaysia vice-president and general manager Serdar Kizilcik at the launch of the project.

A long-term project focused on improving quality of care for children and young adults with type 1 diabetes has been launched.

Called Changing Diabetes in Children (CDiC), the project sees Novo Nordisk partnering with Malaysian Endocrine and Metabolic Society (MEMS) and pharmaceutical company Roche.